Sales of 37 medicines suspended in high-risk areas in Guangdong, "yellow code" customers are not allowed to buy medicines in stores

With the escalation of epidemic prevention and control, the Guangdong Provincial Drug Administration recently issued the "Notice of the Office of the Guangdong Provincial Drug Administration on Strengthening Measures for the Prevention and Control of the Epidemic of Drug Retail Enterprises" (hereinafter referred to as the "Notice")
.
The "Notice" clarified that drug retail companies in medium and high-risk areas across the province will suspend the sale of drugs in the "List of Drugs that Need to be Registered and Reported During the Epidemic Period" until they are restored to low-risk areas

Previously, the Guangdong Drug Administration and the Provincial Health Commission organized relevant medical and pharmacological experts to focus on the study and judgment of the medication habits and clinical prescriptions of patients with suspected new crown symptoms, and optimized the original "Catalogue of Antipyretic Drugs that Need Real-Name Registration Reports" , Formulated the "Drugs List for Real-Name Registration Reporting During the Epidemic Period" and issued it for implementation on May 29
.

The catalog has been optimized from the original 43 antipyretic drugs and 25 antitussive, antiviral, and antibiotic drugs to 37 common and essential drugs for cold and fever patients who purchase drugs in pharmacies, including 20 Chinese patent medicines and 17 chemical drugs
.
The optimized catalogue focuses on improving the scientificity, sensitivity and targeting of the “sentinel” monitoring of retail pharmacies, and improving the “accuracy, timeliness and coverage” of registration reports, so as to make full use of the “sentinel” of epidemic prevention and control.

The "Notice" requires that drug retail companies in the province further implement the real-name registration and reporting system for drugs in the "Catalog", requiring customers to enter the store to take their temperature and show their health code.
If a customer's health code "yellow code" is found, they are not allowed to enter the store to purchase.
Medicine, and guide to a medical institution for treatment
.
Pharmaceutical retail companies should post relevant requirements and warning signs in conspicuous locations in their business premises, and publicize the aforementioned measures to the public

From now on, drug network sales companies are not allowed to sell "Catalog" drugs to individual consumers whose delivery addresses are in Guangzhou, Shenzhen, and Foshan, until the epidemic situation in that area is effectively controlled, and the specific recovery time will be notified separately
.

The Guangdong Food and Drug Administration emphasized that local municipal bureaus should supervise and urge enterprises to implement the main responsibilities, implement the territorial supervision responsibilities of drug retail enterprises, and promptly notify the above-mentioned requirements to drug retail enterprises (including drug online sales enterprises and third-party platforms) in their jurisdictions to comply and implement them.
Cover supervision and inspection, and increase the frequency and intensity of inspections on high-risk companies
.
Local and municipal bureaus should set up supervision teams to strengthen supervision and inspections, and strictly investigate and deal with units and enterprises that fail to implement them in accordance with the law

List of drugs that require real-name registration during the epidemic

【Proprietary Chinese Medicine】

【Chemical Medicine】